Panic disorder with agoraphobia
diseaseOn this page
Summary
Panic disorder with agoraphobia (MONDO:0044144) is a disease and 7 clinical trials. A subtype of agoraphobia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 7
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | panic disorder with agoraphobia |
| Mondo ID | MONDO:0044144 |
| ICD-10-CM | F40.01 |
| NCIT | C97194 |
| SNOMED CT | 35607004 |
| UMLS | C0236800 |
| MedGen | 472969 |
| Is cancer (heuristic) | no |
Also known as: panic disorder with agoraphobia
Disease family
This is a subtype of agoraphobia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disorder › mental disorder › anxiety disorder › phobic disorder › agoraphobia › panic disorder with agoraphobia
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 7.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 7 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04793828 | Not specified | RECRUITING | A Transdiagnostic, Self-guided Internet Intervention (Velibra) for Waitlist Patients With Anxiety Disorders |
| NCT05967468 | Not specified | ACTIVE_NOT_RECRUITING | Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder |
| NCT01680237 | Not specified | TERMINATED | Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia |
| NCT03061448 | Not specified | COMPLETED | Internet-based Exposure Therapy for Panic Disorder |
| NCT03547180 | Not specified | COMPLETED | Mechanisms of Treatment Change in Panic Disorder and Agoraphobia |
| NCT03885453 | Not specified | UNKNOWN | Construction of a Questionnaire on Panic Disorder and Agoraphobia |
| NCT04568109 | Not specified | COMPLETED | Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.